2 The Diabetes Control and Complications Trial Research Group. The effect of intensive insulin treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med1993; 329: 977–986.
3.
3 UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet1998; 352: 837–853.
5 Lange P Parner J Schnohr P Jensen G . Copenhagen City Heart Study: Longitudinal analysis of ventilatory capacity in diabetic and non-diabetic adults. Eur Respir J2002; 20: 1406–1412.
6.
6 Skyler JS Jovanovic L Reis J Duggan W . for the Inhaled Human Insulin type 1 Diabetes Study Group. 2 year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes. Diabetes Care2007; 30: 579–585.
7.
7 Barnett AH Lange P Dreyer M Serdarevic-Pehar M . on behalf of the Exubera phase 3 study group. Long term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetes. Int J Clin Pract2007; 61: 1614–1625.
8.
8 Niranjan V McBrayer DG Ramirez LC Raskin P Hsia CCW . Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus. Am J Med1997; 103: 504–513.
9.
9 Guazzi M Oreglia I Guazzi MD . Insulin improves alveolar-capillary membrane gas conductance in type 2 diabetes. Diabetes Care2002; 25: 1802–1806.
10.
10 Antonelli Incalzi R Fuso L Pitocco D Basso S Trove A Longobardi A . Decline of neuroadrenergic bronchial innervation and respiratory function in type 1 diabetes mellitus: a longitudinal study. Diabetes Metab Res Rev2007; 23: 311–316.
11.
11 Andersen H Schmitz O Nielsen S . Decreased isometric muscle strength after acute hyperglycemia in type 1 diabetic patients. Diabet Med2005; 22: 1401–1407.
